Successful High-Dose Ribavirin Treatment of Respiratory Syncytial Virus-Induced Tracheobronchitis and Pneumonia Occuring Pre-Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

被引：0
|
作者：
Gueller, Saskia [1 ]
Duenzinger, Ulrich [1 ]
Wolf, Timo [1 ]
Mousset, Sabine [1 ]
Martin, Hans [1 ]
Serve, Hubert [1 ]
Bug, Gesine [1 ]
机构：
[1] Goethe Univ Frankfurt, Dept Med, Frankfurt, Germany
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：478 / 478
页数：1
相关论文
共 40 条
  • [1] Respiratory syncytial virus-induced tracheobronchitis and pneumonia occuring pre-engraftment in allogeneic haematopoietic stem cell transplant recipients can be safely treated with high-dose ribavirin
    Gueller, S.
    Duenzinger, U.
    Wolf, T.
    Mousset, S.
    Martin, H.
    Serve, H.
    Bug, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S215 - S215
  • [2] Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients
    Gueller, S.
    Duenzinger, U.
    Wolf, T.
    Ajib, S.
    Mousset, S.
    Berger, A.
    Martin, H.
    Serve, H.
    Bug, G.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (04) : 435 - 440
  • [3] Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
    Gaffney K.J.
    Urban T.A.
    Lucena M.
    Rybicki L.
    Majhail N.S.
    Mossad S.B.
    Clinical Hematology International, 2023, 5 (2-3) : 65 - 70
  • [4] Is Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe?
    Jain, Shilpa R.
    Phoompoung, Pakpoom
    Husain, Shahid
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (12) : 2234 - 2235
  • [5] Pre-engraftment cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes
    Solano, Carlos
    Gimenez, Estela
    Albert, Eliseo
    Maria Mateo, Eva
    Gomez, Montserrat
    Goterris, Rosa
    Perez, Ariadna
    Amat, Paula
    Carlos Hernandez-Boluda, Juan
    Poch, Marc
    Luis Pinana, Jose
    Navarro, David
    BONE MARROW TRANSPLANTATION, 2019, 54 (01) : 90 - 98
  • [6] Pre-engraftment cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes
    Carlos Solano
    Estela Giménez
    Eliseo Albert
    Eva María Mateo
    Montserrat Gómez
    Rosa Goterris
    Ariadna Pérez
    Paula Amat
    Juan Carlos Hernández-Boluda
    Marc Poch
    José Luis Piñana
    David Navarro
    Bone Marrow Transplantation, 2019, 54 : 90 - 98
  • [7] Is Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe? Reply
    Foolad, Farnaz
    Chemaly, Roy F.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (12) : 2235 - 2236
  • [8] Treatment of respiratory tract infections caused by respiratory syncytial virus and/or adenovirus with intravenous ribavirin in recipients of allogeneic hematopoietic stem cell transplants
    Schleuning, M
    Buxbaum-Conradi, H
    Jäger, G
    Kolb, HJ
    BONE MARROW TRANSPLANTATION, 2003, 31 : S87 - S87
  • [9] Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients
    Foolad, Farnaz
    Aitken, Samuel L.
    Shigle, Terri Lynn
    Prayag, Amrita
    Ghantoji, Shashank
    Ariza-Heredia, Ella
    Chemaly, Roy F.
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (10) : 1641 - 1649
  • [10] Prompt Treatment of Respiratory Syncytial Virus with Inhaled Ribavirin and WIG in High Risk Allogeneic Stem Cell Transplant Recipients Significantly Diminishes Mortality
    Bourgouin, Patrick
    Krakow, Elizabeth Florence
    Roy, Jean
    Ahmad, Imran
    Bernard, Lea
    Delisle, Jean-Sebastien
    Kiss, Thomas
    Lachance, Silvy
    Roy, Denis-Claude
    Sauvageau, Guy
    Cohen, Sandra
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S258 - S259
1234